Must be nice when you have $6B to spend anytime you want on a "bolt-on" acquisition. Novartis' CEO, Joe Jimenez says they have cash laying around for such an acquisition and they won't have to worry about compromising any potential dividends either. More cash than sense I guess. Apparently, the company is bugeting the $6B and is looking for "sweet spot" candidates that would fall in the $2B to $4B range. But in a pinch, the company says $10B shouldn't be a problem. We all should have such troubles.
Posted by Bruce Lehr Dec 9th 2013.